Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
RxNorm 2562997
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2562997 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML Injectable Suspension
(Atom ID: 12656869)
PSN
Prescribable Name (PSN):
Influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension
(Atom ID: 12658049)
SY